AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
May 6, 2025
30870_dirs_2025-05-05_320d6fbc-2bab-4dff-88f5-2bc205c48876.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-05-05
Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-05 | Common Stock | S | 4002 | $36.68 | Disposed | 60687 | Direct |
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18